跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
格华止 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Metformin Hydrochloride Sustained-release Tablets
Approved
化学药品
Metformin Hydrochloride Sustained-release Tablets
MERCK SERONO LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Dec 11, 2021
Approval ID
8H1Or9FPmWD
Company
MERCK SERONO LIMITED
Type
化学药品
Approval Details
Approval Id
8H1Or9FPmWD
Approval Number
国药准字HJ20170029
Generic Name
盐酸二甲双胍缓释片
Generic Name En
Metformin Hydrochloride Sustained-release Tablets
Trade Name
格华止
Drug Type
化学药品
Dosage Form
片剂
Strength
0.5g
Reg Date
2021-12-11
Expired Date
2026-12-10
Company Name
MERCK SERONO LIMITED
Production Company Name
Merck Healthcare KGaA
Company Detail Path
/organization/merck-serono-limited
Production Company Detail Path
/organization/merck-healthcare-kgaa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 11, 2021
Approval ID
8H1Or9FPmWD
Type
化学药品
Back to NMPA Approvals
